New Alzheimer's treatment Aduhelm may be too costly for many seniors, deepening inequities
The price tag of $56,000 per year for Biogen's new Alzheimer's treatment could come with a bitter pill for some Medicare beneficiaries: out-of-pocket costs of up to $11,500. That f…